Nicolas Peyraud, from MSF (Médecins Sans Frontière), is the first student who has completed his Master of Advanced Studies of Vaccinology. He successfully defended his master thesis on “Microarray patch product development for measles containing vaccines”. He received his Master diploma fro: the Lausanne University in January 2019.
January 7, 2019
The bachelor, initiated in collaboration with the Medical Faculty of the Geneva University, consists in part of a total of 68 web-based interactive clinical cases dispatched in 4 modules including i/ digestion & metabolism, reproduction, and cell growth & aging, 2/ Heart, kidney and lungs, 3/ Neurosciences and bones and joints and 4/ Defense & immunity and infection.
Each year, a 2nd year and 3rd year class enrolls about 25 students.
January 7, 2019
The University of Lausanne (UNIL) is offering an International Master in Vaccinology (IMVACC) developed by the Swiss Vaccine Research Institute (SVRI) and the Health Sciences e-Training Foundation (HSeT) in collaboration with the Lausanne University Hospital (CHUV)
The 2016 class. All students have completed their first year and all passed the final exam. Presently one student defended his master project and his is the first to receive the 60 ETCS diploma from the University of Lausanne. The other students will defend their master thesis in the coming years
The 2018 class. All students have completed the first year and will take the final exam on January 16 2019. They will present their master thesis project
The 2019 class. Ten candidates have successfully registered and are starting the program with a kickoff meeting on January 14-16 in Lausanne, Switzerland
Diploma (DAS), certificate (CAS) of advanced
studies in translational nephrology.
The first four students/postdocs have achieved
the DAS and the diploma will be given personally
to them during the site visit of NCCR kidney.CH
program in June 2018. For the two other postdocs,
the DAS diploma will be awarded once they have
submitted their publication. DAS.
Master of advanced studies (MAS) in
Translation and Entrepreneurship in Medicine.
The first cohort has been so far very successful:
- Six patents have been filed in 2017 and 3
more are planned in 2018
- Two startups have been founded by the end
of 2017 with a start in 2018.
Another will start in the fall of 2018.
A newly funded PhD Fellowship program
from the Swiss School of Public Health
GlobalP3HS is an innovative Swiss doctoral program designed to competitively recruit exceptionally talented students from all over the world. Young scientists interested in proposing, learning, and performing cutting-edge research in public health sciences and keen to become the next generation of public health leaders in both the academic and non-academic sector, are invited to apply for one of, in total, 50 doctoral fellowships of up to 42 months in duration.
For more information: https://ssphplus.ch/en/globalp3hs/